Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of TANC2 protein | affects expression | 20106945
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of TANC2 mRNA | increases expression | 20458559
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TANC2 mRNA | decreases expression | 19150397
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of TANC2 mRNA | increases expression | 20106945
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of TANC2 mRNA | affects binding|increases activity|increases expression | 19710929
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.52 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
2.35 | 11798837 19825857 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
4.02 | 16434500 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
10.27 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
10.27 | 19483382 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.73 | 11589617 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
3.23 | 21507988 12619106 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
3.23 | 15553829 16217749 11135700 14691202 15073043 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
5.49 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.47 | 12490120 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.35 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.35 | 12371664 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.63 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.63 | 19176532 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
1.86 | 20501625 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.63 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
1.89 | 10525206 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.50 | 15213294 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.56 | 18249437 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.85 | 12083418 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.70 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
4.70 | 12903497 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
15.33 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
15.33 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
15.33 | 19236843 20131406 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.62 | 12639820 12168785 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.70 | 16904648 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.76 | 8708960 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.73 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.96 | 15720958 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.48 | 18467677 19772884 16221962 19176532 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.53 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.20 | 10903974 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.85 | 16306350 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.05 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.52 | 8314463 18776723 10903974 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
3.04 | 12371664 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
2.98 | 15070760 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
4.17 | 12560223 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.85 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.69 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
4.13 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
2.18 | 16968895 19850784 20471514 16467208 17050201 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.43 | 12018890 12679006 16823087 19225113 17107899 17869043 11468182 17217047 12712474 11161223 15336539 16966277 17712046 15213294 19075265 15622746 19642359 16891316 17649720 16330433 15748426 19035177 16112521 9834237 16331271 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.79 | 16882451 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
8.09 | 18177683 15890375 2125692 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
8.09 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
8.09 | 16377806 20007298 15890375 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
6.72 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
6.72 | 20377131 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.62 | 15213294 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
2.61 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
2.61 | 11798837 19825857 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.40 | 16801185 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.35 | 15949261 19549372 11468182 19417148 14977855 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.99 | 16239165 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
5.28 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
3.32 | 16882451 16105982 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.26 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.22 | 16411023 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.40 | 16624393 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.09 | 17405874 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.05 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.61 | 19348381 18481113 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
3.33 | 10525206 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.88 | 20558911 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
2.49 | 12452020 16624393 19769630 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
2.62 | 15580305 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.57 | 19927285 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.55 | 12371664 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
3.22 | 19131511 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.32 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.53 | 19058328 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
4.40 | 16646077 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
1.86 | 17007042 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
3.36 | 19014326 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.50 | 15213294 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
2.59 | 11780464 12845720 20435036 12973940 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.59 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.05 | 17120751 |